EMF-Portal | Literature search results

2023, Li X, Liu K, Xing L, Rubinsky B

A review of tumor treating fields (TTFields): advancements in clinical applications and mechanistic insights [review]

Radiol Oncol 57 (3): 279-291

2023, Cerna M, Drizdal T

Implementation of Time Reversal Focusing on Hyperthermia Treatment of Brain Tumours [tech./dosim.]

2023 Photonics & Electromagnetics Research Symposium (PIERS), Prague, Czech Republic. IEEE: pp. 1267-1274; ISBN 9798350312850

2023, Ballo MT, Conlon P, Lavy-Shahaf G, Kinzel A, Vymazal J, Rulseh AM

Association of Tumor Treating Fields (TTFields) therapy with survival in newly diagnosed glioblastoma: a systematic review and meta-analysis [review]

J Neurooncol 164 (1): 1-9

2023, Barkhoudarian G, Badruddoja M, Blondin N, Chowdhary S, Cobbs C, Duic JP, Flores JP, Fonkem E, McClay E, Nabors LB, Salacz M, Taylor L, Vaillant B, Gill J, Kesari S

An expanded safety/feasibility study of the EMulate Therapeutics Voyager™ System in patients with recurrent glioblastoma [med. app.]

CNS Oncol 12 (3): CNS102

2023, Mehdizadeh R, Madjid Ansari A, Forouzesh F, Shahriari F, Shariatpanahi SP, Salaritabar A, Javidi MA

P53 status, and G2/M cell cycle arrest, are determining factors in cell-death induction mediated by ELF-EMF in glioblastoma [med./bio.]

Sci Rep 13: 10845

2023, Yoshikawa MH, Rabelo NN, Telles JPM, Figueiredo EG

[details] Modifiable risk factors for glioblastoma: a systematic review and meta-analysis [review]

Neurosurg Rev 46 (143): 143

2023, Fishman H, Monin R, Dor-On E, Kinzel A, Haber A, Giladi M, Weinberg U, Palti Y

Tumor Treating Fields (TTFields) increase the effectiveness of temozolomide and lomustine in glioblastoma cell lines [med./bio.]

J Neurooncol 163 (1): 83-94

2023, Abed T, Ganser K, Eckert F, Stransky N, Huber SM

Ion channels as molecular targets of glioblastoma electrotherapy [review]

Front Cell Neurosci 17: 1133984

2023, Zhou Y, Xing X, Zhou J, Jiang H, Cen P, Jin C, Zhong Y, Zhou R, Wang J, Tian M, Zhang H

Therapeutic potential of tumor treating fields for malignant brain tumors [review]

Cancer Rep 6 (5): e1813

2023, Smothers AR, Henderson JR, O'Connell JJ, Stenbeck JM, Dean D, Harvey TG, Booth BW

Efficacy and selectivity of tumor-treating field therapy for triple-negative breast cancer cells via in-house delivery device [med./bio.]

Discov Oncol 14 (1): 34

2023, Cruz N, Herculano-Carvalho M, Roque D, Faria CC, Cascão R, Ferreira HA, Reis CP, Matela N

Highlighted Advances in Therapies for Difficult-To-Treat Brain Tumours Such as Glioblastoma [review]

Pharmaceutics 15 (3): 928

2023, Isaković J, Šerer K, Barišić B, Mitrečić D

Mesenchymal stem cell therapy for neurological disorders: The light or the dark side of the force? [basics]

Front Bioeng Biotechnol 11: 1139359

2023, Lin L, McCraw MR, Uluutku B, Liu Y, Yan D, Soni V, Horkowitz A, Yao X, Limanowski R, Solares SD, Beilis II, Keidar M

Cell Membrane Oscillations under Radiofrequency Electromagnetic Modulation [med./bio.]

Langmuir 39 (9): 3320-3331

2023, Ravin R, Cai TX, Li A, Briceno N, Pursley RH, Garmendia-Cedillos M, Pohida T, Wang H, Zhuang Z, Cui J, Morgan NY, Williamson NH, Gilbert MR, Basser PJ

"Tumor Treating Fields" delivered via electromagnetic induction have varied effects across glioma cell lines and electric field amplitudes [med./bio.]

bioRxiv: the Preprint Server for Biology (bioRxiv), 2023.01.18.524504

2023, Wu H, Liu L, Ma M, Zhang Y

Modulation of blood-brain tumor barrier for delivery of magnetic hyperthermia to brain cancer [med./bio.]

J Control Release 355: 248-258

2023, Gökçek-Saraç Ç, Şimşek T, Karakurt S

Cytoprotective effects of low-frequency pulsed electromagnetic field against oxidative stress in glioblastoma cells [med./bio.]

Gen Physiol Biophys 42 (1): 97-106

2023, Yahyapour R, Khoei S, Kordestani Z, Larizadeh MH, Jomehzadeh A, Amirinejad M, Ahmadi-Zeidabadi M

Comparative study of extremely low-frequency electromagnetic field, radiation, and temozolomide administration in spheroid and monolayer forms of the glioblastoma cell line (T98) [med./bio.]

Curr Radiopharm 16 (2): 123 - 132

2023, Sitnikov DS, Revkova VA, Ilina IV, Gurova SA, Komarov PS, Struleva EV, Konoplyannikov MA, Kalsin VA, Baklaushev VP

Studying the genotoxic effects of high intensity terahertz radiation on fibroblasts and CNS tumor cells [med./bio.]

J Biophotonics 16 (1): e202200212

2023, Jin T, Dou Z, Zhao Y, Jiang B, Xu J, Zhang B, Wei B, Dong F, Zhang J, Sun C

Skull defect increases the tumor treating fields strength without detrimental thermogenic effect: A computational simulating research [tech./dosim.]

Cancer Med 12 (2): 1461-1470

2022, Salvador E, Kessler AF, Domröse D, Hörmann J, Schaeffer C, Giniunaite A, Burek M, Tempel-Brami C, Voloshin T, Volodin A, Zeidan A, Giladi M, Ernestus RI, Löhr M, Förster CY, Hagemann C

Tumor Treating Fields (TTFields) Reversibly Permeabilize the Blood-Brain Barrier In Vitro and In Vivo [med./bio.]

Biomolecules 12 (10): 1348

2022, Shams S, Patel CB

Anti-cancer mechanisms of action of therapeutic alternating electric fields (tumor treating fields [TTFields]) [review]

J Mol Cell Biol 14 (8): mjac047

2022, Vymazal J, Kazda T, Novak T, Slanina P, Sroubek J, Klener J, Hrbac T, Syrucek M, Rulseh AM

Eighteen years' experience with tumor treating fields in the treatment of newly diagnosed glioblastoma [med. app.]

Front Oncol 12: 1014455

2022, Anadkat MJ, Lacouture M, Friedman A, Horne ZD, Jung J, Kaffenberger B, Kalmadi S, Ovington L, Kotecha R, Abdullah HI, Grosso F

Expert guidance on prophylaxis and treatment of dermatologic adverse events with Tumor Treating Fields (TTFields) therapy in the thoracic region [basics]

Front Oncol 12: 975473

2022, Du X, Chen C, Xiao Y, Cui Y, Yang L, Li X, Liu X, Wang R, Tan B